Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-12-22
|
pubmed:abstractText |
A method is reported for conjugating an analog of 4'-(aminomethyl)-4,5',8- trimethylpsoralen to methylphophonate oligonucleotides. This method enables the psoralen moiety to be coupled to the phosphonate backbone between any two desired bases in a sequence. When hybridized to a target mRNA, the psoralen moiety can be directed toward a uridine base and, in turn, can undergo a photo-addition reaction with the target under UV irradiation at 365 nm. Several different non-nucleotide-based amino-linker reagents have been prepared for incorporation into methylphosphonate oligonucleotides by standard phosphonamidite chemistry. In addition, an N-hydroxysuccinimide activated ester analog of 4'-[(3-carboxypropionamido)methyl]-4,5',8- trimethylpsoralen has been synthesized for conjugation to the amino-linker moieties. Using this approach, we have prepared a number of psoralen-methylphosphonate-oligonucleotide conjugates which are complementary to the chimeric bcr/abl mRNA associated with chronic myelogenous leukemia. Solution hybridization studies with a 440-base subfragment of the bcr/abl RNA have shown that the psoralen moiety does not adversely affect duplex stability. Polyacrylamide gel electrophoresis analyses have demonstrated that the psoralen-oligonucleotide conjugates undergo photo-addition to the RNA in a sequence-specific manner. Optimal photo-addition occurs when the psoralen moiety is inserted adjacent to one or more adenine residues in the oligonucleotide sequence, particularly between adenine and thymine (5'-3'). This internal labeling approach greatly increases the number of potential target sites available for photo-cross-linking experiments.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cross-Linking Reagents,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides,
http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Psoralens,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Trioxsalen,
http://linkedlifedata.com/resource/pubmed/chemical/aminomethyltrioxsalen,
http://linkedlifedata.com/resource/pubmed/chemical/methylphosphonic acid
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1043-1802
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
366-74
|
pubmed:dateRevised |
2001-3-23
|
pubmed:meshHeading |
pubmed-meshheading:1420436-Base Sequence,
pubmed-meshheading:1420436-Chimera,
pubmed-meshheading:1420436-Cross-Linking Reagents,
pubmed-meshheading:1420436-Leukemia, Myeloid,
pubmed-meshheading:1420436-Molecular Sequence Data,
pubmed-meshheading:1420436-Oligonucleotides,
pubmed-meshheading:1420436-Organophosphorus Compounds,
pubmed-meshheading:1420436-Photochemistry,
pubmed-meshheading:1420436-Psoralens,
pubmed-meshheading:1420436-RNA, Messenger,
pubmed-meshheading:1420436-Structure-Activity Relationship,
pubmed-meshheading:1420436-Trioxsalen
|
pubmed:articleTitle |
A non-nucleotide-based linking method for the preparation of psoralen-derivatized methylphosphonate oligonucleotides.
|
pubmed:affiliation |
Genta Inc., San Diego, California 92121.
|
pubmed:publicationType |
Journal Article
|